Monday, 24 March 2014

The UK service level audit of insulin pump therapy in adults

The prevalence of continuous subcutaneous insulin infusion use in the UK falls well below the expectation of NICE (15–20%) and that of other European countries (> 15%) and the USA (40%). This may be attributable, in part, to lack of healthcare professional time needed for identification and training of new pump therapy users (Diabetic Medicine)


TANDEM: understanding diabetes and tuberculosis

urrently, more than 80% of adults with diabetes live in low-income or middle-income countries, and diabetes generally presents at a younger age in these countries.1 People with diabetes are three times more likely to develop active tuberculosis than are people without diabetes (The Lancet Diabetes & Endocrinology)


Lord Ashcroft: By tackling diabetes, we can boost the nation’s wealth as well as people’s health

Education programmes can be a real lifeline and, by giving people the tools they need to manage their own condition, they can actually save money in the long run


Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and Non-Asians

GLP-1 analogues lower HbA1c more in Asian-dominant studies than in non-Asian-dominant studies. Further studies are warranted to explore the potential mechanisms of the ethnic difference (Diabetes, Obesity and Metabolism)

No comments:

Post a Comment